Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases

Bibliography

• Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281(5380):1191-3
   PubMed Web of Science ®Google Scholar
• Beutelspacher SC, Tan PH, Mcclure MO, et al. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant 2006;6(6):1320-30
   PubMed Web of Science ®Google Scholar
• Munn DH, Sharma MD, Lee JR, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002;297(5588):1867-70
   PubMed Web of Science ®Google Scholar
• Mackenzie CR, Hadding U, Daubener W. Interferon-γ-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J Infect Dis 1998;178(3):875-8
   PubMed Web of Science ®Google Scholar
• Leonhardt RM, Lee SJ, Kavathas PB, Cresswell P. Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis. Infect Immun 2007;75(11):5105-17
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004;4(10):762-74
   PubMed Web of Science ®Google Scholar
• Puccetti P, Fallarino F. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 2008;40(1):101-5
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006;176(11):6752-61
   PubMed Web of Science ®Google Scholar
• Chen W, Liang X, Peterson AJ, et al. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 2008;181(8):5396-404
   PubMed Web of Science ®Google Scholar
• Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008;451(7175):211-5
   PubMed Web of Science ®Google Scholar
• Dai H, Dai Z. The role of tryptophan catabolism in acquisition and effector function of memory T cells. Curr Opin Organ Transpl 2008;13(1):31-5
   PubMedGoogle Scholar
• Liu Z, Dai H, Wan N, et al. Suppression of memory CD8 T cell generation and function by tryptophan catabolism. J Immunol 2007;178(7):4260-6
   PubMedGoogle Scholar
• Puccetti P. On watching the watchers: IDO and type I/II IFN. Eur J Immunol 2007;37(4):876-9
   PubMedGoogle Scholar
• Manlapat AK, Kahler DJ, Chandler PR, et al. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. Eur J Immunol 2007;37(4):1064-71
   PubMed Web of Science ®Google Scholar
• Lopez AS, Alegre E, Lemaoult J, et al. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. Mol Immunol 2006;43(14):2151-60
   PubMed Web of Science ®Google Scholar
• Lopez AS, Alegre E, Diaz-Lagares A, et al. Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages. Immunol Lett 2008;117(1):91-5
   PubMed Web of Science ®Google Scholar
• Belladonna ML, Grohmann U, Guidetti P, et al. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J Immunol 2006;177(1):130-7
   PubMed Web of Science ®Google Scholar
• Grohmann U, Volpi C, Fallarino F, et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 2007;13(5):579-86
   PubMed Web of Science ®Google Scholar
• Adikari SB, Lian H, Link H, et al. Interferon-γ-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis. Clin Exp Immunol 2004;138(2):230-6
   PubMed Web of Science ®Google Scholar
• Frumento G, Rotondo R, Tonetti M, et al. Tryptophan-derived catabolites are responsible for inhibition of  T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 2002;196(4):459-68
   PubMed Web of Science ®Google Scholar
• Terness P, Bauer TM, Rose L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002;196(4):447-57
   PubMed Web of Science ®Google Scholar
• Hayashi T, Mo JH, Gong X, et al. 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci USA 2007;104(47):18619-24
   PubMed Web of Science ®Google Scholar
• Taher YA, Piavaux BJ, Gras R, et al. Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model. J Allergy Clin Immunol 2008;121(4):983-91, e982
   PubMed Web of Science ®Google Scholar
• Romani L, Zelante T, De Luca A, et al. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008;180(8):5157-62
   PubMed Web of Science ®Google Scholar
• De Luca A, Montagnoli C, Zelante T et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 2007;179(9):5999-6008
   PubMed Web of Science ®Google Scholar
• Della Chiesa M, Carlomagno S, Frumento G, et al. The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood 2006;108(13):4118-25
   PubMedGoogle Scholar
• Molano A, Illarionov PA, Besra GS, et al. Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase. Immunol Lett 2008;117(1):81-90
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol 2006;14(4):183-9
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999;20(10):469-73
   PubMedGoogle Scholar
• Belladonna ML, Orabona C, Grohmann U, Puccetti P. TGF-β and kynurenines as the key to infectious tolerance. Trends Mol Med 2009;15(2):41-9
   PubMed Web of Science ®Google Scholar
• Puccetti P, Grohmann U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation. Nat Rev Immunol 2007;7(10):817-23
   PubMed Web of Science ®Google Scholar
• Brusko TM, Wasserfall CH, Agarwal A, et al. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+ CD25+ regulatory T cells. J Immunol 2005;174(9):5181-6
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002;9(10):1069-77
   PubMed Web of Science ®Google Scholar
• Platten M, Ho PP, Youssef S, et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 2005;310(5749):850-5
   PubMed Web of Science ®Google Scholar
• Tan PH, Lota AS. Interaction of current cancer treatments and the immune system: implications for breast cancer therapeutics. Expert Opin Pharmacother 2008;9(15):2639-60
   PubMed Web of Science ®Google Scholar
• Muller AJ, Prendergast GC. Marrying immunotherapy with chemotherapy: why say IDO? Cancer Res 2005;65(18):8065-8
   PubMed Web of Science ®Google Scholar
• Boyland E, Williams DC. The metabolism of tryptophan. 2. The metabolism of tryptophan in patients suffering from cancer of bladder. Biochem J 1959;64:578-84
   Google Scholar
• Ozaki Y, Edelstein MP, Duch DS. Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon γ. Proc Natl Acad Sci USA 1988;85(4):1242-6
   PubMed Web of Science ®Google Scholar
• Carlin JM, Borden EC, Sondel PM, Byrne GI. Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leukoc Biol 1989;45(1):29-34
   PubMed Web of Science ®Google Scholar
• Burke F, Knowles RG, East N, Balkwill FR. The role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-γ in vivo. Int J Cancer 1995;60(1):115-22
   PubMed Web of Science ®Google Scholar
• Schroecksnadel K, Winkler C, Fuith LC, Fuchs D. Tryptophan degradation in patients with gynecological cancer correlates with immune activation. Cancer Lett 2005;223(2):323-9
   PubMed Web of Science ®Google Scholar
• Uyttenhove C, Pilotte L, Theate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003;9(10):1269-74
   PubMed Web of Science ®Google Scholar
• Denz H, Orth B, Weiss G, et al. Weight loss in patients with hematological neoplasias is associated with immune system stimulation. Clin Investig 1993;71(1):37-41
   PubMedGoogle Scholar
• Giusti RM, Maloney EM, Hanchard B, et al. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma. Cancer Epidemiol Biomarkers Prev 1996;5(9):699-704
   PubMed Web of Science ®Google Scholar
• Okamoto A, Nikaido T, Ochiai K, et al. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells. Clin Cancer Res 2005;11(16):6030-9
   PubMed Web of Science ®Google Scholar
• Ino K, Yoshida N, Kajiyama H, et al. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer 2006;95(11):1555-61
   PubMed Web of Science ®Google Scholar
• Huang A, Fuchs D, Widner B, et al. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer 2002;86(11):1691-6
   PubMed Web of Science ®Google Scholar
• Grant RS, Naif H, Espinosa M, Kapoor V. IDO induction in IFN-γ activated astroglia: a role in improving cell viability during oxidative stress. Redox Rep 2000;5(2-3):101-4
   PubMed Web of Science ®Google Scholar
• Moffett JR, Els T, Espey MG, et al. Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes. Exp Neurol 1997;144(2):287-301
   PubMedGoogle Scholar
• Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol 2003;81(4):247-65
   PubMed Web of Science ®Google Scholar
• Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 1996;14(1):69-77
   PubMed Web of Science ®Google Scholar
• Peter BJ, Kent HM, Mills IG, et al. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science 2004;303(5657):495-9
   PubMed Web of Science ®Google Scholar
• Miaczynska M, Christoforidis S, Giner A, et al. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 2004;116(3):445-56
   PubMedGoogle Scholar
• Ge K, Duhadaway J, Sakamuro D, et al. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity. Int J Cancer 2000;85(3):376-83
   PubMed Web of Science ®Google Scholar
• Ge K, Duhadaway J, Du W, et al. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci USA 1999;96(17):9689-94
   PubMedGoogle Scholar
• Tajiri T, Liu X, Thompson PM, et al. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Clin Cancer Res 2003;9(9):3345-55
   PubMed Web of Science ®Google Scholar
• Muller AJ, Duhadaway JB, Donover PS, et al. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med 2005;11(3):312-9
   PubMed Web of Science ®Google Scholar
• Pfefferkorn ER. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984;81(3):908-12
   PubMed Web of Science ®Google Scholar
• Brown RR, Ozaki Y, Datta SP, et al. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv Exp Med Biol 1991;294:425-35
   PubMedGoogle Scholar
• Yoshida R, Hayaishi O. Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1978;75(8):3998-4000
   PubMed Web of Science ®Google Scholar
• Yoshida R, Imanishi J, Oku T, et al. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc Natl Acad Sci USA 1981;78(1):129-32
   PubMed Web of Science ®Google Scholar
• Schroten H, Spors B, Hucke C, et al. Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. Neuropediatrics 2001;32(4):206-10
   PubMed Web of Science ®Google Scholar
• Friberg M, Jennings R, Alsarraj M, et al. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer 2002;101(2):151-5
   PubMed Web of Science ®Google Scholar
• Sarsero JP, Merino E, Yanofsky C. A Bacillus subtilis operon containing genes of unknown function senses tRNATrp charging and regulates expression of the genes of tryptophan biosynthesis. Proc Natl Acad Sci USA 2000;97(6):2656-61
   PubMedGoogle Scholar
• Xie G, Bonner CA, Jensen RA. Dynamic diversity of the tryptophan pathway in chlamydiae: reductive evolution and a novel operon for tryptophan recapture. Genome Biol 2002;3(9):research0051
   PubMedGoogle Scholar
• Fleckner J, Martensen PM, Tolstrup AB, et al. Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 1995;7(1):70-7
   PubMedGoogle Scholar
• Sanni LA, Thomas SR, Tattam BN, et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol 1998;152(2):611-9
   PubMed Web of Science ®Google Scholar
• Guillonneau C, Mintern JD, Hubert FX, et al. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci USA 2009;106(16):6724-9
   PubMedGoogle Scholar
• Baggiolini M, Wymann MP. Turning on the respiratory burst. Trends Biochem Sci 1990;15(2):69-72
   PubMed Web of Science ®Google Scholar
• Sun Y. Indoleamine 2,3-dioxygenase–a new antioxidant enzyme. Mater Med Pol 1989;21(3):244-50
   PubMedGoogle Scholar
• Hayaishi O. Utilization of superoxide anion by indoleamine oxygenase-catalyzed tryptophan and indoleamine oxidation. Adv Exp Med Biol 1996;398:285-9
   PubMedGoogle Scholar
• Satoh MS, Poirier GG, Lindahl T. Dual function for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry 1994;33(23):7099-106
   PubMed Web of Science ®Google Scholar
• Bieganowska K, Hollsberg P, Buckle GJ, et al. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol 1999;162(3):1765-71
   PubMed Web of Science ®Google Scholar
• Moffett JR, Espey MG, Namboodiri MA. Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system. Cell Tissue Res 1994;278(3):461-9
   PubMed Web of Science ®Google Scholar
• Moffett JR, Blinder KL, Venkateshan CN, Namboodiri MA. Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs. Cell Tissue Res 1998;293(3):525-34
   PubMedGoogle Scholar
• Heyliger SO, Mazzio EA, Soliman KF. The anti-inflammatory effects of quinolinic acid in the rat. Life Sci 1999;64(14):1177-87
   PubMedGoogle Scholar
• Refaeli Y, Van Parijs L, Alexander SI, Abbas AK. Interferon γ is required for activation-induced death of T lymphocytes. J Exp Med 2002;196(7):999-1005
   PubMed Web of Science ®Google Scholar
• Tan PH, Beutelspacher SC, Xue SA, et al. Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 2005;105(10):3824-32
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Tuting T, Steitz J, et al. Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity. Gene Ther 2000;7(3):249-54
   PubMed Web of Science ®Google Scholar
• Tetsutani K, To H, Torii M, et al. Malaria parasite induces tryptophan-related immune suppression in mice. Parasitology 2007;134(Pt 7):923-30
   PubMedGoogle Scholar
• Bourreau E, Ronet C, Darcissac E, et al. Intralesional Treg suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis. Infect Immun 2009;77(4):1465-74
   PubMedGoogle Scholar
• Orabona C, Pallotta MT, Volpi C, et al. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proc Natl Acad Sci USA 2008;105(52):20828-33
   PubMed Web of Science ®Google Scholar
• Huengsberg M, Winer JB, Gompels M, et al. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem 1998;44(4):858-62
   PubMedGoogle Scholar
• Look MP, Altfeld M, Kreuzer KA, et al. Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease. AIDS Res Hum Retroviruses 2000;16(13):1215-21
   PubMedGoogle Scholar
• Gisslen M, Larsson M, Norkrans G, et al. Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection. AIDS Res Hum Retroviruses 1994;10(8):947-51
   PubMedGoogle Scholar
• Fuchs D, Moller AA, Reibnegger G, et al. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett 1991;28(3):207-11
   PubMed Web of Science ®Google Scholar
• Zangerle R, Widner B, Quirchmair G, et al. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Clin Immunol 2002;104(3):242-7
   PubMed Web of Science ®Google Scholar
• Chen YB, Li SD, He YP, et al. Immunosuppressive effect of IDO on T cells in patients with chronic hepatitis B. Hepatol Res 2009;39(5):463-8
   PubMed Web of Science ®Google Scholar
• Cady SG, Sono M. 1-Methyl-DL-tryptophan, β-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch Biochem Biophys 1991;291(2):326-33
   PubMed Web of Science ®Google Scholar
• Mellor AL, Baban B, Chandler P, et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 2003;171(4):1652-5
   PubMed Web of Science ®Google Scholar
• Gurtner GJ, Newberry RD, Schloemann SR, et al. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 2003;125(6):1762-73
   PubMed Web of Science ®Google Scholar
• Munn DH, Mellor AL. IDO and tolerance to tumors. Trends Mol Med 2004;10(1):15-8
   PubMed Web of Science ®Google Scholar
• Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007;117(5):1147-54
   PubMed Web of Science ®Google Scholar
• Schroecksnadel K, Winkler C, Wirleitner B, et al. Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro. Clin Exp Immunol 2005;140(1):41-5
   PubMed Web of Science ®Google Scholar
• Winkler C, Wirleitner B, Schroecksnadel K, et al. St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro. Biol Chem 2004;385(12):1197-202
   PubMed Web of Science ®Google Scholar
• Winkler C, Wirleitner B, Schroecksnadel K, et al. In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells. Planta Med 2004;70(3):205-10
   PubMedGoogle Scholar
• Girgin G, Baydar T, Ledochowski M, et al. Immunomodulatory effects of Turkish propolis: changes in neopterin release and tryptophan degradation. Immunobiology 2009;214(2):129-34
   PubMedGoogle Scholar
• Jeong YI, Kim SW, Jung ID, et al. Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cδ-STAT1 signaling pathway in interferon-γ-stimulated murine dendritic cells. J Biol Chem 2009;284(6):3700-8
   PubMed Web of Science ®Google Scholar
• Nikoo S, Bozorgmehr M, Namdar Ahmadabad, et al. The 14kDa protein molecule isolated from garlic suppresses indoleamine 2, 3-dioxygenase metabolites in mononuclear cells in vitro. Iran J Allergy Asthma Immunol 2008;7(4):203-8
   PubMedGoogle Scholar
• Volgraf M, Lumb JP, Brastianos HC, et al. Biomimetic synthesis of the IDO inhibitors exiguamine A and B. Nat Chem Biol 2008;4(9):535-7
   PubMed Web of Science ®Google Scholar
• Kumar S, Malachowski WP, Duhadaway JB, et al. Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. J Med Chem 2008;51(6):1706-18
   PubMed Web of Science ®Google Scholar
• Kumar S, Jaller D, Patel B, et al. Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase. J Med Chem 2008;51(16):4968-77
   PubMed Web of Science ®Google Scholar
• Yen MC, Lin CC, Chen YL, et al. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. Clin Cancer Res 2009;15(2):641-9
   PubMed Web of Science ®Google Scholar
• Lake RA, Robinson BW. Immunotherapy and chemotherapy–a practical partnership. Nat Rev Cancer 2005;5(5):397-405
   PubMed Web of Science ®Google Scholar
• Polak L, Turk JL. Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity. Nature 1974;249(458):654-6
   PubMedGoogle Scholar
• Machiels JP, Reilly RT, Emens LA, et al. Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 2001;61(9):3689-97
   PubMed Web of Science ®Google Scholar
• Emens LA, Machiels JP, Reilly RT, Jaffee EM. Chemotherapy: friend or foe to cancer vaccines? Curr Opin Mol Ther 2001;3(1):77-84
   PubMed Web of Science ®Google Scholar
• Rad AN, Pollara G, Sohaib SM, et al. The differential influence of allogeneic tumor cell death via DNA damage on dendritic cell maturation and antigen presentation. Cancer Res 2003;63(16):5143-50
   PubMed Web of Science ®Google Scholar
• Ossina NK, Cannas A, Powers VC, et al. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997;272(26):16351-7
   PubMed Web of Science ®Google Scholar
• Muller AJ, Sharma MD, Chandler PR, et al. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. Proc Natl Acad Sci USA 2008;105(44):17073-8
   PubMed Web of Science ®Google Scholar
• Belladonna ML, Volpi C, Bianchi R, et al. Cutting edge: Autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells. J Immunol 2008;181(8):5194-8
   PubMed Web of Science ®Google Scholar
• Huang AY, Golumbek P, Ahmadzadeh M, et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994;264(5161):961-5
   PubMed Web of Science ®Google Scholar
• Yu P, Spiotto MT, Lee Y, et al. Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med 2003;197(8):985-95
   PubMed Web of Science ®Google Scholar
• Van Mierlo GJ, Boonman ZF, Dumortier HM, et al. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication. J Immunol 2004;173(11):6753-9
   PubMedGoogle Scholar
• Nowak AK, Lake RA, Marzo AL, et al. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J Immunol 2003;170(10):4905-13
   PubMed Web of Science ®Google Scholar
• Hargadon KM, Brinkman CC, Sheasley-O'Neill SL, et al. Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes. J Immunol 2006;177(9):6081-90
   PubMedGoogle Scholar
• Kraal G, Samsom JN, Mebius RE. The importance of regional lymph nodes for mucosal tolerance. Immunol Rev 2006;213:119-30
   PubMedGoogle Scholar
• Munn DH, Mellor AL. The tumor-draining lymph node as an immune-privileged site. Immunol Rev 2006;213:146-58
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Huang RR, Lee J, et al. Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol 2006;6(9):659-70
   PubMed Web of Science ®Google Scholar
• Von Bergwelt-Baildon MS, Popov A, Saric T et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 2006;108(1):228-37
   PubMed Web of Science ®Google Scholar
• Lee JR, Dalton RR, Messina JL, et al. Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. Lab Invest 2003;83(10):1457-66
   PubMed Web of Science ®Google Scholar
• Lee JH, Torisu-Itakara H, Cochran AJ, et al. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res 2005;11(1):107-12
   PubMed Web of Science ®Google Scholar
• Munn DH, Sharma MD, Hou D, et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 2004;114(2):280-90
   PubMed Web of Science ®Google Scholar
• Munn DH, Sharma MD, Baban B, et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005;22(5):633-42
   PubMed Web of Science ®Google Scholar
• Agaugue S, Perrin-Cocon L, Coutant F, et al. 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. J Immunol 2006;177(4):2061-71
   PubMed Web of Science ®Google Scholar
• Lob S, Konigsrainer A, Schafer R, et al. Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood 2008;111(4):2152-4
   PubMed Web of Science ®Google Scholar
• Hou DY, Muller AJ, Sharma MD, et al. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res 2007;67(2):792-801
   PubMed Web of Science ®Google Scholar
• Munn DH, Mellor AL, Rossi M, Young JW. Dendritic cells have the option to express IDO-mediated suppression or not. Blood 2005;105(6):2618
   PubMed Web of Science ®Google Scholar
• Sawitzki B, Kingsley CI, Oliveira V, et al. IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005;201(12):1925-35
   PubMed Web of Science ®Google Scholar
• Swanson KA, Zheng Y, Heidler KM, et al. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 2004;30(3):311-8
   PubMed Web of Science ®Google Scholar
• Quan J, Tan PH, Macdonald A, Friend PJ. Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges. Expert Opin Biol Ther 2008;8(11):1705-19
   PubMed Web of Science ®Google Scholar
• Fallarino F, Orabona C, Vacca C, et al. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int Immunol 2005;17(11):1429-38
   PubMed Web of Science ®Google Scholar
• Grohmann U, Orabona C, Fallarino F, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002;3(11):1097-101
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Hwang KW, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003;4(12):1206-12
   PubMed Web of Science ®Google Scholar
• Liu H, Liu L, Visner GA. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia–reperfusion injury. Am J Transplant 2007;7(10):2291-300
   PubMed Web of Science ®Google Scholar
• Sono M, Roach MP, Coulter ED, Dawson JH. Heme-containing oxygenases. Chem Rev 1996;96(7):2841-88
   PubMed Web of Science ®Google Scholar
• Hirata F, Hayaishi O. Studies on indoleamine 2,3-dioxygenase. I. Superoxide anion as substrate. J Biol Chem 1975;250(15):5960-6
   PubMed Web of Science ®Google Scholar
• Hayaishi O, Hirata F, Ohnishi T, et al. Indoleamine 2,3-dioxygenase: incorporation of 18O2– and 18O2 into the reaction products. J Biol Chem 1977;252(10):3548-50
   PubMed Web of Science ®Google Scholar
• Hirata F, Ohnishi T, Hayaishi O. Indoleamine 2,3-dioxygenase. Characterization and properties of enzyme. O2- complex. J Biol Chem 1977;252(13):4637-42
   PubMedGoogle Scholar
• Sono M, Taniguchi T, Watanabe Y, Hayaishi O. Indoleamine 2,3-dioxygenase. Equilibrium studies of the tryptophan binding to the ferric, ferrous, and CO-bound enzymes. J Biol Chem 1980;255(4):1339-45
   PubMedGoogle Scholar
• Ozaki Y, Reinhard JF Jr, Nichol CA, Duch DS. Cofactor activity of dihydroflavin mononucleotide and tetrahydrobiopterin for murine epididymal indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 1986;137(3):1106-11
   PubMed Web of Science ®Google Scholar
• Ozaki Y, Nichol CA, Duch DS. Utilization of dihydroflavin mononucleotide and superoxide anion for the decyclization of L-tryptophan by murine epididymal indoleamine 2,3-dioxygenase. Arch Biochem Biophys 1987;257(1):207-16
   PubMed Web of Science ®Google Scholar
• Vottero E, Mitchell DA, Page MJ, et al. Cytochrome b5 is a major reductant in vivo of human indoleamine 2,3-dioxygenase expressed in yeast. FEBS Lett 2006;580(9):2265-8
   PubMedGoogle Scholar
• Maghzal GJ, Thomas SR, Hunt NH, Stocker R. Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells. J Biol Chem 2008;283(18):12014-25
   PubMedGoogle Scholar
• Brandacher G, Cakar F, Winkler C, et al. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation. Kidney Int 2007;71(1):60-7
   PubMed Web of Science ®Google Scholar
• Beutelspacher SC, Pillai R, Watson MP, et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006;36(3):690-700
   PubMed Web of Science ®Google Scholar
• Forrest CM, Kennedy A, Stone TW, et al. Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. Adv Exp Med Biol 2003;527:287-95
   PubMed Web of Science ®Google Scholar
• Schroecksnadel K, Kaser S, Ledochowski M, et al. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J Rheumatol 2003;30(9):1935-9
   PubMed Web of Science ®Google Scholar
• Wolf AM, Wolf D, Rumpold H, et al. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol 2004;113(1):47-55
   PubMed Web of Science ®Google Scholar
• Kwidzinski E, Bunse J, Aktas O, et al. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J 2005;19(10):1347-9
   PubMed Web of Science ®Google Scholar
• Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004;114(2):270-9
   PubMed Web of Science ®Google Scholar
• Nakahara M, Nagayama Y, Saitoh O, et al. Expression of immunoregulatory molecules by thyrocytes protects nonobese diabetic H2h4 mice from developing autoimmune thyroiditis. Endocrinology 2009;150(3):1545-51
   PubMedGoogle Scholar
• Maneechotesuwan K, Wamanuttajinda V, Kasetsinsombat K, et al. Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma. J Allergy Clin Immunol 2009;123(1):239-48
   PubMedGoogle Scholar
• Wang J, Simonavicius N, Wu X, et al. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 2006;281(31):22021-8
   PubMed Web of Science ®Google Scholar
• Bianco NR, Kim SH, Ruffner MA, Robbins PD. Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum 2009;60(2):380-9
   PubMed Web of Science ®Google Scholar
• Segal BH, Romani L, Puccetti P. Chronic granulomatous disease. Cell Mol Life Sci 2009;66(4):553-8
   PubMed Web of Science ®Google Scholar
• Fallarino F, Vacca C, Orabona C, et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8α + dendritic cells. Int Immunol 2002;14(1):65-8
   PubMed Web of Science ®Google Scholar
• Guillonneau C, Hill M, Hubert FX, et al. CD40Ig treatment results in allograft acceptance mediated by CD8+ CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenase. J Clin Invest 2007;117(4):1096-106
   PubMed Web of Science ®Google Scholar
• Degauque N, Lair D, Dupont A, et al. Dominant tolerance to kidney allografts induced by anti-donor MHC class II antibodies: cooperation between T and non-T CD103+ cells. J Immunol 2006;176(7):3915-22
   PubMed Web of Science ®Google Scholar
• Fallarino F, Asselin-Paturel C, Vacca C, et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 2004;173(6):3748-54
   PubMed Web of Science ®Google Scholar
• Tan PH, Beutelspacher SC, Wang YH, et al. Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol Ther 2005;11(5):790-800
   PubMed Web of Science ®Google Scholar
• Hwu P, Du MX, Lapointe R, et al. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of  T cell proliferation. J Immunol 2000;164(7):3596-9
   PubMed Web of Science ®Google Scholar
• Terness P, Chuang JJ, Bauer T, et al. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO? Blood 2005;105(6):2480-6
   PubMedGoogle Scholar
• Pree I, Bigenzahn S, Fuchs D, et al. CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine-2, 3-dioxygenase. Transplantation 2007;83(5):663-7
   PubMed Web of Science ®Google Scholar
• Orabona C, Puccetti P, Vacca C, et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 2006;107(7):2846-54
   PubMed Web of Science ®Google Scholar
• Orabona C, Belladonna ML, Vacca C, et al. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. J Immunol 2005;174(11):6582-6
   PubMed Web of Science ®Google Scholar
• Sharma MD, Baban B, Chandler P, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 2007;117(9):2570-82
   PubMed Web of Science ®Google Scholar
• Thomas SR, Terentis AC, Cai H, et al. Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem 2007;282(33):23778-87
   PubMed Web of Science ®Google Scholar
• Tan PH, Xue SA, Manunta M, et al. Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol 2006;26(3):462-7
   PubMed Web of Science ®Google Scholar
• Couzin J, Kaiser J. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow. Science 2005;307(5712):1028
   PubMed Web of Science ®Google Scholar
• Carmen IH. A death in the laboratory: the politics of the Gelsinger aftermath. Mol Ther 2001;3(4):425-8
   PubMed Web of Science ®Google Scholar
• Tan PH, Janes SE, Handa AI, Friend PJ: More trouble ahead; is gene therapy coming of age? Expert Opin Biol Ther 2008;8(5):561-7
   PubMed Web of Science ®Google Scholar
• Tan PH, Tan PL, George AJ, Chan CL. Gene therapy for transplantation with viral vectors – how much of the promise has been realized? Expert Opin Biol Ther 2006;6(8):759-72
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348(3):255-6
   PubMed Web of Science ®Google Scholar
• Laurence JM, Wang C, Zheng M, et al. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection. Liver Transpl 2009;15(2):233-41
   PubMedGoogle Scholar
• Rayner SA, Larkin DF, George AJ. TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. Invest Ophthalmol Vis Sci 2001;42(7):1568-73
   PubMed Web of Science ®Google Scholar
• HIV Vaccine Trial Network: November 2007 HVTN Conference Presentations. Available from: http://www.hvtn.org/science/1107.html [Last access 13 May 2008]
   Google Scholar
• Tan PH, Chan CL, George AJ. Strategies to improve non-viral vectors - potential applications in clinical transplantation. Expert Opin Biol Ther 2006;6(6):619-30
   PubMed Web of Science ®Google Scholar
• Orabona C, Grohmann U, Belladonna ML, et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat Immunol 2004;5(11):1134-42
   PubMed Web of Science ®Google Scholar
• Guillemin GJ, Smythe G, Takikawa O, Brew BJ. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 2005;49(1):15-23
   PubMed Web of Science ®Google Scholar
• Clinical trial: 1-methyl-D-tryptophan in treating patients with relapsed or refractory solid tumors. Available from: http://clinicaltrials.gov/show/NCT00788086 (2008) [Last accessed 13 May 2009]
   Google Scholar
• Clinical trial: A phase 1 study of 1-methyl-D-tryptophan in patients with advanced malignancies. Available from: http://clinicaltrials.gov/ct2/show/NCT00617422 (2009) [Last accessed 13 May 2009]
   Google Scholar
• Katz JB, Muller AJ, Prendergast GC. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 2008;222:206-21
   PubMed Web of Science ®Google Scholar
• Popov A, Schultze JL. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med 2008;86(2):145-60
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol 2008;8(1):74-80
   PubMed Web of Science ®Google Scholar
• Popov A, Abdullah Z, Wickenhauser C, et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 2006;116(12):3160-70
   PubMed Web of Science ®Google Scholar
• Gasparri AM, Jachetti E, Colombo B, et al. Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNγ. Mol Cancer Ther 2008;7(12):3859-66
   PubMedGoogle Scholar
• Hoshi M, Ito H, Fujigaki H, et al. Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity. Leuk Res 2009;33(1):39-45
   PubMed Web of Science ®Google Scholar
• Corm S, Berthon C, Imbenotte M, et al. Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-γ. Leuk Res 2009;33(3):490-4
   PubMed Web of Science ®Google Scholar
• Curti A, Pandolfi S, Valzasina B, et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25– into CD25+ T regulatory cells. Blood 2007;109(7):2871-7
   PubMed Web of Science ®Google Scholar
• Tang XQ, Zhao ZG, Wang HX, et al. Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006;14(3):539-42
   PubMedGoogle Scholar
• Riesenberg R, Weiler C, Spring O, et al. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma. Clin Cancer Res 2007;13(23):6993-7002
   PubMed Web of Science ®Google Scholar
• Feder-Mengus C, Wyler S, Hudolin T, et al. High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. Eur J Cancer 2008;44(15):2266-75
   PubMedGoogle Scholar
• Kai S, Goto S, Tahara K, et al. Inhibition of indoleamine 2,3-dioxygenase suppresses NK cell activity and accelerates tumor growth. J Exp Ther Oncol 2003;3(6):336-45
   PubMedGoogle Scholar
• Liebau C, Baltzer Aw, Schmidt S, et al: Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. Anticancer Res 2002;22(2A):931-6
   PubMed Web of Science ®Google Scholar
• Zheng X, Koropatnick J, Li M, et al. Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference. J Immunol 2006;177(8):5639-46
   PubMed Web of Science ®Google Scholar
• Beutelspacher SC, Serbecic N. Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase. Klin Monatsbl Augenheilkd 2008;225(8):703-7
   PubMedGoogle Scholar
• Chen PW, Mellon JK, Mayhew E, et al. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. Exp Eye Res 2007;85(5):617-25
   PubMedGoogle Scholar
• Polak ME, Borthwick NJ, Gabriel FG, et al. Mechanisms of local immunosuppression in cutaneous melanoma. Br J Cancer 2007;96(12):1879-87
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Weinberg V, Darragh T, Smith-mccune K. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol 2008;1(5):412-20
   PubMed Web of Science ®Google Scholar
• Nakamura T, Shima T, Saeki A, et al. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci 2007;98(6):874-81
   PubMed Web of Science ®Google Scholar
• Sedlmayr P, Semlitsch M, Gebru G, et al. Expression of indoleamine 2,3-dioxygenase in carcinoma of human endometrium and uterine cervix. Adv Exp Med Biol 2003;527:91-5
   PubMedGoogle Scholar
• Yoshida N, Ino K, Ishida Y, et al. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model. Clin Cancer Res 2008;14(22):7251-9
   PubMed Web of Science ®Google Scholar
• Ino K, Yamamoto E, Shibata K, et al. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival. Clin Cancer Res 2008;14(8):2310-7
   PubMed Web of Science ®Google Scholar
• Brandacher G, Perathoner A, Ladurner R, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 2006;12(4):1144-51
   PubMed Web of Science ®Google Scholar
• Tinder TL, Subramani DB, Basu GD, et al. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. J Immunol 2008;181(5):3116-25
   PubMed Web of Science ®Google Scholar
• Witkiewicz A, Williams TK, Cozzitorto J, et al. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection. J Am Coll Surg 2008;206(5):849-54; discussion 854-846
   PubMed Web of Science ®Google Scholar
• Ishio T, Goto S, Tahara K, et al. Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma. J Gastroenterol Hepatol 2004;19(3):319-26
   PubMed Web of Science ®Google Scholar
• Pan K, Wang H, Chen MS, et al: Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma. J Cancer Res Clin Oncol 2008;134(11):1247-53
   Google Scholar
• Basu GD, Tinder TL, Bradley JM, et al. Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO. J Immunol 2006;177(4):2391-402
   PubMed Web of Science ®Google Scholar
• Karanikas V, Zamanakou M, Kerenidi T, et al. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. Cancer Biol Ther 2007;6(8):1258-62
   PubMed Web of Science ®Google Scholar
• Hucke C, Mackenzie CR, Adjogble KD, et al. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase. Infect Immun 2004;72(5):2723-30
   PubMed Web of Science ®Google Scholar
• Mackenzie CR, Worku D, Daubener W. Regulation of IDO-mediated bacteriostasis in macrophages: role of antibiotics and anti-inflammatory agents. Adv Exp Med Biol 2003;527:67-76
   PubMedGoogle Scholar
• Heseler K, Spekker K, Schmidt SK, et al. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-γ-induced tryptophan degradation. FEMS Immunol Med Microbiol 2008;52(2):273-81
   PubMedGoogle Scholar
• Murr C, Gerlach D, Widner B, et al. Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes. Med Microbiol Immunol 2001;189(3):161-3
   PubMedGoogle Scholar
• Pantoja LG, Miller RD, Ramirez JA, et al. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity. Infect Immun 2000;68(11):6478-81
   PubMed Web of Science ®Google Scholar
• Sakash JB, Byrne GI, Lichtman A, Libby P. Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection. Infect Immun 2002;70(7):3959-61
   PubMed Web of Science ®Google Scholar
• Rottenberg ME, Gigliotti Rothfuchs A, Gigliotti D, et al. Regulation and role of IFN-γ in the innate resistance to infection with Chlamydia pneumoniae. J Immunol 2000;164(9):4812-8
   PubMed Web of Science ®Google Scholar
• Carlin JM, Ozaki Y, Byrne GIR, et al. Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia 1989;45(6):535-41
   PubMedGoogle Scholar
• Mackler AM, Barber EM, Takikawa O, Pollard JW. Indoleamine 2,3-dioxygenase is regulated by IFN-γ in the mouse placenta during Listeria monocytogenes infection. J Immunol 2003;170(2):823-30
   PubMed Web of Science ®Google Scholar
• De Sousa R, Ismail N, Nobrega SD et al. Intralesional expression of mRNA of interferon-γ, tumor necrosis factor-α, interleukin-10, nitric oxide synthase, indoleamine-2,3-dioxygenase, and RANTES is a major immune effector in Mediterranean spotted fever rickettsiosis. J Infect Dis 2007;196(5):770-81
   PubMed Web of Science ®Google Scholar
• Moreau M, Lestage J, Verrier D, et al. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis 2005;192(3):537-44
   PubMed Web of Science ®Google Scholar
• Greub G, Desnues B, Raoult D, Mege JL. Lack of microbicidal response in human macrophages infected with Parachlamydia acanthamoebae. Microbes Infect 2005;7(4):714-9
   PubMed Web of Science ®Google Scholar
• Yoshida R, Urade Y, Tokuda M, Hayaishi O. Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc Natl Acad Sci USA 1979;76(8):4084-6
   PubMed Web of Science ®Google Scholar
• Brown BD, Sitia G, Annoni A, et al. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 2007;109(7):2797-805
   PubMed Web of Science ®Google Scholar
• Potula R, Poluektova L, Knipe B, et al. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in animal model of HIV-1 encephalitis. Blood 2005;106(7):2382-90
   PubMed Web of Science ®Google Scholar
• Burudi EM, Marcondes MC, Watry DD, et al. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J Virol 2002;76(23):12233-41
   PubMed Web of Science ®Google Scholar
• Depboylu C, Reinhart TA, Takikawa O, et al. Brain virus burden and indoleamine-2,3-dioxygenase expression during lentiviral infection of rhesus monkey are concomitantly lowered by 6-chloro-2′,3′-dideoxyguanosine. Eur J Neurosci 2004;19(11):2997-3005
   PubMed Web of Science ®Google Scholar
• Obojes K, Andres O, Kim KS, et al. Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J Virol 2005;79(12):7768-76
   PubMed Web of Science ®Google Scholar
• Bozza S, Fallarino F, Pitzurra L, et al. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 2005;174(5):2910-8
   PubMed Web of Science ®Google Scholar
• Nagineni CN, Pardhasaradhi K, Martins MC, et al. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun 1996;64(10):4188-96
   PubMed Web of Science ®Google Scholar
• Daubener W, Spors B, Hucke C, et al. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect Immun 2001;69(10):6527-31
   PubMed Web of Science ®Google Scholar
• Fujigaki S, Saito K, Takemura M, et al. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2, 3-dioxygenase. Infect Immun 2002;70(2):779-86
   PubMed Web of Science ®Google Scholar
• Hansen AM, Driussi C, Turner V, et al. Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue. Redox Rep 2000;5(2-3):112-5
   PubMed Web of Science ®Google Scholar
• Hansen AM, Ball HJ, Mitchell AJ, et al. Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium. Int J Parasitol 2004;34(12):1309-19
   PubMed Web of Science ®Google Scholar
• Bertera S, Alexander AM, Crawford ML, et al. Gene combination transfer to block autoimmune damage in transplanted islets of Langerhans. Exp Diabesity Res 2004;5(3):201-10
   PubMedGoogle Scholar
• Alexander AM, Crawford M, Bertera S, et al. Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 2002;51(2):356-65
   PubMed Web of Science ®Google Scholar
• Jalili RB, Rayat GR, Rajotte RV, Ghahary A. Suppression of islet allogeneic immune response by indoleamine 2, 3 dioxygenase-expressing fibroblasts. J Cell Physiol 2007;213(1):137-43
   PubMed Web of Science ®Google Scholar
• Haspot F, Seveno C, Dugast AS, et al. Anti-CD28 Antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR Class II B7 regulatory cells. Am J Transplant 2005;5(10):2339-48
   PubMed Web of Science ®Google Scholar
• Li J, Meinhardt A, Roehrich ME, et al. Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival. Am J Physiol Heart Circ Physiol 2007;293(6):H3415-23
   PubMed Web of Science ®Google Scholar
• Pan TL, Lin CL, Chen CL, et al. Identification of the indoleamine 2,3-dioxygenase nucleotide sequence in a rat liver transplant model. Transpl Immunol 2000;8(3):189-94
   PubMed Web of Science ®Google Scholar
• Li Y, Tredget EE, Ghaffari A, et al. Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J Invest Dermatol 2006;126(1):128-36
   PubMed Web of Science ®Google Scholar
• Bauer TM, Jiga LP, Chuang JJ, et al. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Int 2005;18(1):95-100
   PubMed Web of Science ®Google Scholar
• Liu H, Liu L, Fletcher BS, Visner GA. Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury. Am J Respir Crit Care Med 2006;173(5):566-72
   PubMed Web of Science ®Google Scholar
• Liu H, Liu L, Fletcher BS, Visner GA. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. Faseb J 2006;20(13):2384-6
   PubMed Web of Science ®Google Scholar